Federal Register of Legislation - Australian Government

Primary content

No. 1/2014 Directions/Other as made
This instrument directs the Independent Hospital Pricing Authority to determine the costs for the refined list of items associated with conducting clinical trials in Australia (above and beyond the standard costs of care).
Administered by: Health
Exempt from sunsetting by the Legislation (Exemptions and Other Matters) Regulation 2015 s11 item 03
Made 19 Dec 2014
Registered 27 Jan 2015
Tabled HR 09 Feb 2015
Tabled Senate 09 Feb 2015

 

 

Direction to the Independent Hospital Pricing Authority on the performance of its functions under section 226 of the National Health Reform Act 2011 - No. 1/2014

 

 

I, PETER DUTTON, Minister for Health, acting under subsection 226(1) of the National Health Reform Act 2011 (the Act), having consulted with the Standing Council on Health, DIRECT that the Independent Hospital Pricing Authority make the determination set out in Item 1 of the Schedule to this instrument, and have regard to the matters set out in Item 2 of the Schedule to this instrument.

 

 

 

 

 

Dated:        19th                     December 2014

 

 

 

 

 

 

 

PETER DUTTON

Minister for Health

 

 



Part 1        Preliminary

 

1.               Name of Direction

 

This Instrument is the Direction to the Independent Hospital Pricing Authority on the performance of its functions under section 226 of the National Health Reform Act 2011 - No. 1/2014.

 

2.               Commencement

 

This Direction takes effect on the day after it is registered on the Federal Register of Legislative Instruments.

 

3.               Authority

 

This Direction is made under the National Health Reform Act 2011.

 

4.               Definition

 

In this Direction:

refined list of standard items means the list provided by the Department of Health, having received it from the National Health and Medical Research Council, based on list devised in 2012 that was subsequently reviewed in 2014.

 

5.               Schedule

 

The Schedule to this Instrument describes the direction given to the Independent Hospital Pricing Authority on the performance of its functions.  

 


Schedule   

 

1.      Functions

 

(i)                 By 30 June 2015, the Independent Hospital Pricing Authority, in relation to its function under s. 131(1)(a) of the Act must determine the costs for the refined list of items and any other items (above those costs required for standard care), as determined necessary by the Independent Hospital Pricing Authority, associated with conducting clinical trials in Australia.

 

(ii)               The Independent Hospital Pricing Authority must provide a report on its performance of the activity referred to in Item 1(i) of this Direction to the first meeting of the Standing Council on Health after 30 June 2015.

 

 

2.      Matters the Independent Hospital Pricing Authority is to have regard to

 

(i)                 In performing the activity described in Item 1 of this Schedule, the Independent Hospital Pricing Authority must have regard to the matters set out in subsection 131(3) of the Act.

 

(ii)               In addition, in relation to performing the activity described in Item 1 of this Schedule, the Independent Hospital Pricing Authority may, so far as the Act permits, have regard to the following matters:

 

(a)    the actual activity of each item;

(b)   principles of cost-recovery; and

(c)    submissions from relevant parties, including trial sponsors and private hospitals.